Abstract 1440: Impact of Peripheral Arterial Disease on Health Status: A Comparison With Chronic Heart Failure Patients
Objectives: To further document the experienced burden in patients with peripheral arterial disease (PAD), we aimed to compare the health status of patients with PAD and chronic heart failure (CHF). As a secondary aim, we studied clinical and socio-demographic correlates of health status in both conditions.
Methods: A total of 346 PAD patients and 188 CHF patients from 4 outpatient clinics in the Netherlands completed the Short-Form 12 to assess health status. Information about socio-demographic, clinical risk factors, and disease severity indices was obtained from patients’ medical records. Propensity methodology was applied to enhance comparability between both medical conditions.
Results: Type of medical condition explained differences in health status (F=30.6, P<.0001, Effect Size=0.25). Impaired physical health status was more often reported in PAD patients compared with CHF patients (53.8% vs. 13.0%, P<.0001); impaired mental health status was more noted in CHF patients (53.3% vs. 18.7%, P<.0001). Younger age (P=.03), low education (P=.02), cardiac history (P=.01), and a lower ankle brachial index (P=.01) were associated with worse physical health status in PAD. In PAD, younger age (P=.01) and living without partner (P=.01) was associated with lower mental health status scores. For CHF, patients with comorbid diabetes mellitus (P=.001) and females (P=.001) reported worse physical health. No clinical or socio-demographics were associated with mental health status in CHF.
Conclusions: By contrasting PAD patients’ health status with another chronic disabling condition, the impact of PAD on patients’ physical health status became evident; whereas mental health status was more affected in CHF, patients with PAD reported a greater physical burden as compared with CHF patients. Especially younger, lower-educated patients and patients with a cardiac history or without partner reported higher burden in PAD. Clinicians need to be aware of these differences in order to develop tailor-made disease management programs for different groups of cardiovascular patients.